Source link : https://www.newshealth.biz/health-news/advisory-panel-votes-against-once-weekly-insulin-for-t1d/
In a 7 to 4 vote, an advisory panel to the US Food and Drug Administration (FDA) determined that the potential benefits of the investigational once-weekly basal insulin analog icodec (Novo Nordisk) don’t outweigh the increased risk for hypoglycemia in people with type 1 diabetes. The May 24 meeting of the Endocrinologic and Metabolic Drugs […]
Author : News Health
Publish date : 2024-05-25 16:03:22
Copyright for syndicated content belongs to the linked Source.